Agilent Technologies, Inc. $A Shares Sold by Praxis Investment Management Inc.

Praxis Investment Management Inc. cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 47.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,905 shares of the medical research company’s stock after selling 4,400 shares during the period. Praxis Investment Management Inc.’s holdings in Agilent Technologies were worth $579,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Stone House Investment Management LLC acquired a new stake in shares of Agilent Technologies during the 1st quarter valued at about $30,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies in the 1st quarter worth about $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies in the 2nd quarter worth about $33,000. Zions Bancorporation National Association UT acquired a new stake in Agilent Technologies in the 1st quarter worth about $38,000. Finally, Costello Asset Management INC acquired a new stake in Agilent Technologies in the 1st quarter worth about $47,000.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on A. Barclays lifted their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. Evercore ISI lifted their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Trading Up 0.6%

A opened at $142.01 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The company’s 50 day simple moving average is $127.58 and its two-hundred day simple moving average is $117.83. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The firm has a market capitalization of $40.26 billion, a price-to-earnings ratio of 33.34, a price-to-earnings-growth ratio of 4.61 and a beta of 1.26.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s payout ratio is presently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.